HAEM5:T-prolymphocytic leukaemia: Difference between revisions
| [unchecked revision] | [checked revision] |
mNo edit summary |
mNo edit summary |
||
| Line 295: | Line 295: | ||
|Yes | |Yes | ||
|See note | |See note | ||
|EZH2 inhibitors like tazemetostat have shown efficacy in other hematologic malignancies, providing a rationale for their potential use in T-PLL | |''EZH2'' inhibitors like tazemetostat have shown efficacy in other hematologic malignancies, providing a rationale for their potential use in T-PLL | ||
|- | |- | ||
|''BCOR'' | |''BCOR'' | ||